These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 32912268
1. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation. Bierhoff M, Rijken MJ, Yotyingaphiram W, Pimanpanarak M, van Vugt M, Angkurawaranon C, Nosten F, Ehrhardt S, Thio CL, McGready R. Int J Equity Health; 2020 Sep 10; 19(1):156. PubMed ID: 32912268 [Abstract] [Full Text] [Related]
2. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N. BMC Infect Dis; 2016 Aug 09; 16():393. PubMed ID: 27506549 [Abstract] [Full Text] [Related]
3. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis. Bierhoff M, Angkurawaranon C, Rijken MJ, Sriprawa K, Kobphan P, Nosten FN, van Vugt M, McGready R, Devine A. BMC Pregnancy Childbirth; 2021 Feb 22; 21(1):157. PubMed ID: 33618698 [Abstract] [Full Text] [Related]
4. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa. Mokaya J, Burn EAO, Tamandjou CR, Goedhals D, Barnes EJ, Andersson M, Pinedo-Villanueva R, Matthews PC. BMC Public Health; 2019 Jun 26; 19(1):829. PubMed ID: 31242901 [Abstract] [Full Text] [Related]
6. Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy. Bierhoff M, Nelson KE, Guo N, Jia Y, Angkurawaranon C, Jittamala P, Carrara V, Watthanaworawit W, Ling C, Tongprasert F, van Vugt M, Rijken M, Nosten F, McGready R, Ehrhardt S, Thio CL. BMJ Open; 2020 Sep 13; 10(9):e038123. PubMed ID: 32928858 [Abstract] [Full Text] [Related]
7. Costs of integrating hepatitis B screening and antiviral prophylaxis into routine antenatal care in Burkina Faso: Treat all versus targeted strategies. Gosset A, Drabo S, Carrieri P, Tiendrebeogo ASE, Vincent JP, Tanaka Y, Sombié R, Tall H, Kania D, Boyer S, Shimakawa Y. Int J Gynaecol Obstet; 2024 Jul 13; 166(1):44-61. PubMed ID: 38567863 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand. Janekrongtham C, Punsuwan N, Thitichai P, Lertpiriyasuwat C, Pan-Ngum W, Poovorawan K, Jantarapakde J, Tangkijvanich P. BMJ Open; 2023 Jul 19; 13(7):e067275. PubMed ID: 37474179 [Abstract] [Full Text] [Related]
9. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge]. Yin XR, Liu ZH, Liu ZH, Li J, Zhuang H, Dou XG, Hou JL. Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):262-265. PubMed ID: 29996336 [Abstract] [Full Text] [Related]
10. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Eke AC, Eleje GU, Eke UA, Xia Y, Liu J. Cochrane Database Syst Rev; 2017 Feb 11; 2(2):CD008545. PubMed ID: 28188612 [Abstract] [Full Text] [Related]
11. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. Devine A, Harvey R, Min AM, Gilder MET, Paw MK, Kang J, Watts I, Hanboonkunupakarn B, Nosten F, McGready R. BMC Infect Dis; 2017 Aug 09; 17(1):552. PubMed ID: 28793866 [Abstract] [Full Text] [Related]
12. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX. Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789 [Abstract] [Full Text] [Related]
13. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study. Thompson P, Morgan CE, Ngimbi P, Mwandagalirwa K, Ravelomanana NLR, Tabala M, Fathy M, Kawende B, Muwonga J, Misingi P, Mbendi C, Luhata C, Jhaveri R, Cloherty G, Kaba D, Yotebieng M, Parr JB. Lancet Glob Health; 2021 Nov 20; 9(11):e1600-e1609. PubMed ID: 34416175 [Abstract] [Full Text] [Related]
14. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N. N Engl J Med; 2018 Mar 08; 378(10):911-923. PubMed ID: 29514030 [Abstract] [Full Text] [Related]
15. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L. Vaccine; 2014 Oct 21; 32(46):6091-7. PubMed ID: 25240752 [Abstract] [Full Text] [Related]
16. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting. Duri K, Munjoma PT, Mataramvura H, Mazhandu AJ, Chandiwana P, Marere T, Gumbo FZ, Mazengera LR. BMC Infect Dis; 2023 Oct 27; 23(1):736. PubMed ID: 37891471 [Abstract] [Full Text] [Related]
17. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, Gulsun S, Barcin T, Kalkanli S, Dal MS, Ayaz C. World J Gastroenterol; 2013 Dec 28; 19(48):9377-82. PubMed ID: 24409065 [Abstract] [Full Text] [Related]
18. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria. Ndububa D, Kuti O, Awowole I, Adekanle O, Ijarotimi O, Makinde O, Adeyemi A, Anyabolu C, Ijadunola M. BMJ Open; 2022 Nov 08; 12(11):e063482. PubMed ID: 36351715 [Abstract] [Full Text] [Related]
19. Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique. Loarec A, Nguyen A, Molfino L, Chissano M, Madeira N, Rusch B, Staderini N, Couto A, Ciglenecki I, Antabak NT. Bull World Health Organ; 2022 Jan 01; 100(1):60-69. PubMed ID: 35017758 [Abstract] [Full Text] [Related]
20. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, China Study Group for the Mother-to-Child Transmission of Hepatitis B. N Engl J Med; 2016 Jun 16; 374(24):2324-34. PubMed ID: 27305192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]